ADIPOQ and rheumatoid arthritis: Our results show that in patients with active RA despite csDMARDs and/or bDMARDs, IV TCZ, in combination with MTX (or other csDMARDs) or as monotherapy, may modulate serum levels of adiponectin, notably both the total and HMW isoforms.